This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
ImmunoGen, Inc.
Q22021
7/30/2021
Operator
Immunogen Second Quarter 2021 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Courtney Okonik, Senior Director of Corporate Communications and Investor Relations. Please go ahead.
Courtney Okonik
Senior Director of Corporate Communications and Investor Relations
Good morning, and thank you for joining today's call. Earlier today, we issued a press release that includes a summary of our recent progress and second quarter 2021 financial results. This press release and a recording of this call can be found under the Investors and Media section of our website at immunogen.com. With me today are Mark Kennedy, our President and CEO, Anna Birkenblit, our Chief Medical Officer, and Susan Altshuler, our CFO.
Susan Altshuler
Chief Financial Officer
During today's call, we will review key accomplishments for the business over the last three months, our financial results, and upcoming anticipated events.
You're reading a preview of the IMGN Q2 2021 earnings call.
Free account.
Disclaimer